Child rate, pregnancy outcome and ovarian function in females with classical 21-hydroxylase deficiency

Acta Obstetricia et Gynecologica Scandinavica

Volumn 79, Issue 8, 2000, Pages 687-692

  Jääskeläinen, Jarmo ^a   Hippeläinen, Maritta ^a   Kiekara, Olavi ^a   Voutilainen, Raimo ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

21 Hydroxylase deficiency; Congenital adrenal hyperplasia; Fertility; Pregnancy

Indexed keywords

ANDROGEN; CORTICOSTEROID; CORTICOTROPIN; DEXAMETHASONE; GLUCOCORTICOID; GONADOTROPIN; HYDROCORTISONE; MINERALOCORTICOID; PREDNISOLONE; PREDNISONE; PROGESTERONE; PROLACTIN; SEX HORMONE BINDING GLOBULIN; STEROID; STEROID 21 MONOOXYGENASE;

ADOLESCENT; ADULT; ANDROGEN RELEASE; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; COMPARATIVE STUDY; CORTICOTROPIN BLOOD LEVEL; FEMALE; FEMALE FERTILITY; FEMALE GENITAL SYSTEM; FEMALE INFERTILITY; FINLAND; FOLLICULAR PHASE; GONADAL DISEASE; HUMAN; MENSTRUATION DISORDER; OVARY FUNCTION; OVARY POLYCYSTIC DISEASE; PREGNANCY; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; QUESTIONNAIRE; SALT LOSING NEPHRITIS; STEROID 21 MONOOXYGENASE DEFICIENCY; STEROID BLOOD LEVEL; ULTRASOUND;

ADOLESCENT; ADRENAL HYPERPLASIA, CONGENITAL; ADULT; BIRTH RATE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFERTILITY, FEMALE; MENSTRUAL CYCLE; MIDDLE AGED; OVARY; PREGNANCY; PREGNANCY OUTCOME;

EID: 0033915975     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0412.2000.079008687.x     Document Type: Article

References (18)

1. 1. Miller WL. Genetics, diagnosis and management of 21-hydroxylase deficiency. J Clin Endocrinol Metab 1994; 78: 241-6.
2. 2. Jääskeläinen J, Levo A, Voutilainen R, Partanen J. Population-wide evaluation of disease manifestation in relation to molecular genotype in steroid 21-hydroxylase (CYP21) deficiency: good correlation in a well defined population. J Clin Endocrinol Metab 1997; 82: 3293-7.
3. 3. New MI. Steroid 21-hydroxylase deficiency (congenital adrenal hyperplasia). Am J Med 1995; 98: 2S-8S.
4. 4. Klingensmith GJ, Garcia SC, Jones HW Jr, Migeon CJ, Blizzard RM. Glucocorticoid treatment of girls with congenital adrenal hyperplasia: effects on height, sexual maturation and fertility. J Pediatr 1977; 90: 996-1004.
5. 5. Mulaikal RM, Migeon CJ, Rock JA. Fertility rates in female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N Engl J Med 1987; 316: 178-82.
6. 6. Feldman S, Billaud L, Thalabard J-C, Raux-Demay M-C, Mowszowicz I, Kuttenn F et al. Fertility in women with late-onset adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 1992; 74: 635-9.
7. 7. Helleday J, Siwers B, Ritzen ME. Carlström K. Subnormal androgen and elevated progesterone levels in women treated for congenital virilizing 21-hydroxylase deficiency. J Clin Endocrinol Metab 1993; 76: 933-6.
8. 8. Ehrhardt AA, Evers K, Money J. Influence of androgen and some aspects of sexually dimorphic behavior in women with the late-treated adrenogenital syndrome. Johns Hopkins Med J 1968; 123: 115-22.
9. 9. Kuhnle U, Bullinger M, Schwarz HP, Knorr D. Partnership and sexuality in adult female patients with congenital adrenal hyperplasia. First results of a cross-sectional quality-of-life evaluation. J Steroid Biochem Mol Biol 1993: 45: 123-6.
10. 10. Holmes-Walker DJ, Conway GS, Honour JW, Rumsby G, Jacobs HS. Menstrual disturbance and hypersecretion of progesterone in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clin Endocrinol 1995; 43: 291-6.
11. 11. Lucis OJ, Hobkirk R, Hollenberg CH, MacDonald SA, Blahey P. Polycystic ovaries associated with congenital adrenal hyperplasia. Can Med Assoc J 1966; 94: 1-7.
12. 12. Hague WM, Adams J, Rodda C, Brook CG, de Bryun R, Grant DB et al. The prevalence of polycystic ovaries in patients with congenital adrenal hyperplasia and their close relatives. Clin Endocrinol 1990; 33: 501-10.
13. 13. Ehrmann DA, Barnes RB, Rosenfield RL. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev 1995; 16: 322-53.
14. 14. Barnes RB, Rosenfield RL, Ehrmann DA, Cara JF, Cuttler L, Levitsky LL et al. Ovarian hyperandrogenism as a result of congenital adrenal virilizing disorders: evidence of perinatal masculinization of neuroendocrine function in women. J Clin Endocrinol Metab 1994; 79: 1328-33.
15. 15. Belgorosky A, Chahin S, Rivarola MA. Elevation of serum luteinizing hormone levels during hydrocortisone treatment in infant girls with 21-hydroxylase deficiency. Acta Paediatr 1996; 85: 1172-5.
16. 16. Van Wyk JJ, Gunther DF, Ritzen ME, Wedell A, Cutler GB, Migeon CJ et al. The use of adrenalectomy as a treatment for congenital adrenal hyperplasia. J Clin Endocrinol Metab 1996; 81: 3180-90.
17. 17. Lo JC, Schwitzgebel VM, Tyrrel JB, Fitzgerald PA, Kaplan SL, Conte FA et al. Normal female infants born to mothers with classic congenital adrenal hyperplasia due lo 21-hydroxylase deficiency. J Clin Endocrinol Metab 1999; 84: 930-6.
18. 18. Statistics Finland. Population Structure 1995. Helsinki: Statistics Finland, 1996: 66.